InfuSystem (NYSE:INFU) CFO Acquires $60,970.00 in Stock

InfuSystem Holdings, Inc. (NYSE:INFU) CFO Barry Steele bought 7,000 shares of the firm’s stock in a transaction dated Friday, May 8th. The stock was purchased at an average cost of $8.71 per share, with a total value of $60,970.00. Following the transaction, the chief financial officer directly owned 96,590 shares in the company, valued at approximately $841,298.90. This represents a 7.81% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

InfuSystem Stock Down 2.5%

Shares of INFU traded down $0.21 on Tuesday, reaching $8.16. The stock had a trading volume of 244,052 shares, compared to its average volume of 135,464. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.59 and a current ratio of 1.98. InfuSystem Holdings, Inc. has a 12-month low of $5.08 and a 12-month high of $11.04. The firm has a market capitalization of $164.76 million, a price-to-earnings ratio of 134.86 and a beta of 1.49. The company has a 50-day simple moving average of $9.67 and a 200-day simple moving average of $9.21.

Institutional Trading of InfuSystem

Institutional investors and hedge funds have recently bought and sold shares of the company. Hsbc Holdings PLC lifted its stake in shares of InfuSystem by 5.7% in the first quarter. Hsbc Holdings PLC now owns 30,097 shares of the company’s stock worth $281,000 after buying an additional 1,619 shares in the last quarter. Geode Capital Management LLC increased its holdings in shares of InfuSystem by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 218,123 shares of the company’s stock worth $1,958,000 after purchasing an additional 1,831 shares in the last quarter. HighTower Advisors LLC increased its holdings in shares of InfuSystem by 13.8% in the 4th quarter. HighTower Advisors LLC now owns 21,061 shares of the company’s stock worth $189,000 after purchasing an additional 2,561 shares in the last quarter. Integrated Quantitative Investments LLC raised its stake in shares of InfuSystem by 6.9% in the fourth quarter. Integrated Quantitative Investments LLC now owns 41,484 shares of the company’s stock worth $372,000 after purchasing an additional 2,684 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd lifted its holdings in shares of InfuSystem by 25.8% during the fourth quarter. Dynamic Technology Lab Private Ltd now owns 13,724 shares of the company’s stock valued at $123,000 after purchasing an additional 2,811 shares in the last quarter. 71.13% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Separately, Roth Mkm reaffirmed a “buy” rating and issued a $15.00 target price (up from $14.00) on shares of InfuSystem in a research report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $15.00.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.